Company / Current Assets
vTv Therapeutics Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$89.9M
FY2025
5-year range
$10.7M / $89.9M
FY2021-FY2025
Trend
+135.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $3M in FY2019 to $90M in FY2025.
Based on SEC 10-K filings.
$90M in FY2025 with a 5-year CAGR of +65.6%.
Improved from $11M to $90M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +49.1%
- 5-Year CAGR
- +65.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +65.6%, indicating consistent growth.
- In FY2025, current assets increased 135.9% year-over-year.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $89.9M | +135.9% |
| FY2024 | $38.1M | +257.6% |
| FY2023 | $10.7M | -60.7% |
| FY2022 | $27.1M | +73.4% |
| FY2021 | $15.6M | +116.5% |
| FY2020 | $7.2M | +154.2% |
| FY2019 | $2.8M | -18.3% |
| FY2018 | $3.5M | -82.9% |
| FY2017 | $20.4M | -60.9% |
| FY2016 | $52.1M | -41.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026